JPS6320409B2 - - Google Patents
Info
- Publication number
- JPS6320409B2 JPS6320409B2 JP17386680A JP17386680A JPS6320409B2 JP S6320409 B2 JPS6320409 B2 JP S6320409B2 JP 17386680 A JP17386680 A JP 17386680A JP 17386680 A JP17386680 A JP 17386680A JP S6320409 B2 JPS6320409 B2 JP S6320409B2
- Authority
- JP
- Japan
- Prior art keywords
- bisacodyl
- solid composition
- dioctyl sulfosuccinate
- sodium dioctyl
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 claims description 34
- 229960000503 bisacodyl Drugs 0.000 claims description 33
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 25
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 claims description 21
- 239000008247 solid mixture Substances 0.000 claims description 18
- 239000003826 tablet Substances 0.000 claims description 17
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 9
- 235000002906 tartaric acid Nutrition 0.000 claims description 9
- 239000011975 tartaric acid Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 239000008298 dragée Substances 0.000 claims description 4
- 239000007940 sugar coated tablet Substances 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 5
- 239000008116 calcium stearate Substances 0.000 description 5
- 235000013539 calcium stearate Nutrition 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 229940099112 cornstarch Drugs 0.000 description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000013872 defecation Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17386680A JPS5799521A (en) | 1980-12-11 | 1980-12-11 | Solid composition containing bisacodyl |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17386680A JPS5799521A (en) | 1980-12-11 | 1980-12-11 | Solid composition containing bisacodyl |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5799521A JPS5799521A (en) | 1982-06-21 |
| JPS6320409B2 true JPS6320409B2 (cs) | 1988-04-27 |
Family
ID=15968579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17386680A Granted JPS5799521A (en) | 1980-12-11 | 1980-12-11 | Solid composition containing bisacodyl |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5799521A (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| BR9405836A (pt) * | 1993-02-26 | 1996-01-16 | Procter & Gamble | Forma de dosagem de bisacodil |
| US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
| US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| CA2448927C (en) * | 2001-05-30 | 2011-08-09 | Euro-Celtique, S.A. | Pharmaceutical composition |
| JPWO2004024138A1 (ja) * | 2002-09-10 | 2006-01-05 | 大正製薬株式会社 | ジオクチルソジウムスルホサクシネート配合固形製剤 |
| JP2004123731A (ja) * | 2002-09-10 | 2004-04-22 | Taisho Pharmaceut Co Ltd | ジオクチルソジウムスルホサクシネート配合錠剤 |
| JP4821607B2 (ja) * | 2004-03-10 | 2011-11-24 | 大正製薬株式会社 | 水難溶性薬物配合固形製剤 |
| JP2005255595A (ja) * | 2004-03-10 | 2005-09-22 | Taisho Pharmaceut Co Ltd | ジオクチルソジウムスルホサクシネート配合錠剤 |
| KR100632431B1 (ko) | 2005-02-25 | 2006-10-11 | 보람제약주식회사 | 하제 투명액제의 연질캡슐, 그 조성물 및 제조방법 |
-
1980
- 1980-12-11 JP JP17386680A patent/JPS5799521A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5799521A (en) | 1982-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930010586B1 (ko) | 9-데옥소-11-데옥시-9,11-[이미노[2-(2-메톡시에톡시)에틸리덴]옥시]-(9s)-에리트로마이신을 함유하는 경구투여용 고형 약제학적 제제의 제조방법 | |
| KR0135289B1 (ko) | 제약학적 과립 | |
| US3148124A (en) | Method of preparing sustained release pharmaceutical tablets | |
| KR960005140B1 (ko) | 서방성 매트릭스 제형 | |
| JPH05112445A (ja) | 作用開始を速くし潜在特性を増加させる移送システム | |
| JPH0122245B2 (cs) | ||
| HU228498B1 (en) | Formulation of fast-dissolving efavirenz capsules or tablets and process for the preparation thereof | |
| KR100202154B1 (ko) | 파라세타몰 및 돔페리돈을 함유한 필름 피복 정제 | |
| JP2609022B2 (ja) | ポリカルボフィルカルシウム含有製剤 | |
| JPH09504280A (ja) | センナ剤形 | |
| JPS6320409B2 (cs) | ||
| CN101626755B (zh) | 包含酸不稳定药物的双单元片剂 | |
| JPH0774153B2 (ja) | ロキソプロフェン・ナトリウム含有製剤 | |
| WO1997033574A1 (fr) | Comprimes a liberation prolongee a base de valproate metallique | |
| US4601895A (en) | Delayed-action acetylsalicylic acid formulations for oral administration | |
| EP0324725B1 (en) | A pharmaceutical composition | |
| CA2517120C (en) | Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof | |
| CN104434829B (zh) | 一种石菖蒲挥发油口腔速崩片及其制备方法 | |
| JPH08198761A (ja) | ポリカルボフィルカルシウム含有製剤 | |
| KR100267525B1 (ko) | 시타라빈 옥포스페이트 경질 캡슐제 | |
| JP2669517B2 (ja) | ロキソプロフェン・ナトリウム含有固形製剤 | |
| US6555137B1 (en) | Sucralfate-containing composition and process for the preparation thereof | |
| JP4370050B2 (ja) | クラリスロマイシン錠剤およびその製造法 | |
| GB2061111A (en) | Long acting pharmaceutical composition | |
| JP2936553B2 (ja) | ニセルゴリン含有錠剤 |